Sartorius Stedim Biotech SA Sustainability Reports

The company provides equipment and services for the biopharmaceutical industry to manufacture biotech medications safely and efficiently. Its portfolio covers cell line technologies, cell culture media, bioreactors, and single-use fluid management solutions.

Sector: Manufacturing

Country: France

Exchange: Euronext Paris

LEI: 52990006IVXY7GCSSR39

FIGI: BBG001S8KLN5

23 reports from 2007 to 2025

• Sartorius Stedim Biotech SA 2025 Corporate Governance
• Sartorius Stedim Biotech SA 2024 Corporate Governance
• Sartorius Stedim Biotech SA 2024 Universal Registration Document Including the Annual Financial Report
• Sartorius Stedim Biotech SA 2023 Universal Registration Document Including the Annual Financial Report
• Sartorius Stedim Biotech SA 2022 Universal Registration Document Including the Annual Financial Report